美国成年人中C反应性蛋白-甘油三糖指数和心力衰竭从NHANES 2001-2010年
Ningyi Cheng1,2, Zhicheng Ma3, Yukun Chen1,2
1Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China.
Scientific reports
|July 21, 2025
概括
C反应蛋白 (CRP) - 三甘油糖指数 (CTI) 与心力衰竭 (HF) 的更高患病率有关. 这项研究表明,CTI可以作为一种有价值的生物标志物,用于识别高频风险人群.
科学领域:
- 心血管医学 心血管医学
- 生物标志物 生物标志物
- 代谢综合征是代谢综合征的一种.
背景情况:
- 心力衰竭 (HF) 是一个重要的全球健康问题,发病率和死亡率不断上升.
- C反应蛋白 (CRP) - 三甘油糖指数 (CTI) 是一种用于炎症和胰岛素抵抗的新型复合生物标志物.
- CTI和HF之间的关联尚未被彻底研究.
研究的目的:
- 调查C反应蛋白 (CRP) - 三甘油糖指数 (CTI) 与美国成年人心力衰竭 (HF) 患病率之间的关系.
主要方法:
- 对2001-2010年国家健康和营养检查调查 (NHANES) 的21,974名参与者的横截面分析.
- 基于自我报告的病史进行HF诊断.
- 使用多变量逻辑回归,平滑曲线拟合和子组分析来评估关联和剂量反应关系.
主要成果:
- 与没有HF的人相比,患有HF的人的CTI水平显著更高 (p < 0.001).
- 在CTI水平和HF患病率之间观察到正相关性 (p < 0.001).
- 调整后勤回归显示,HF与较高CTI的几率比率增加,表明非线性剂量反应关系,值为11.657.
结论:
- C反应蛋白 (CRP) - 三甘油糖指数 (CTI) 与美国成年人心力衰竭的存在有关.
- CTI可能具有作为心力衰竭预防和管理策略的预测生物标志物的潜力.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
217
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
217
Coronary Artery Disease I: Introduction
59
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
59
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
341
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
341
Heart Failure II: Pathophysiology
45
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
45
Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Heart Failure I: Introduction
55
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
55


